During the past decade, Cancer Outreach Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Outreach Associates" #1 sponsor was "Helsinn Therapeutics (U.S.), Inc" with 2 trials, followed by "CTI BioPharma" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Heron Therapeutics" with 1 trials sponsored and "Mucosal Therapeutics" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Outreach Associates" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Pharmacia and Upjohn" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Outreach Associates" are "Cancer Cachexia" (2 trials), "Fallopian Tube Cancer" (1 trials), "Lung Cancer" (1 trials), "Nausea and Vomiting" (1 trials) and "Neoplasms, Unknown Primary" (1 trials). Many other conditions were trialed in "Cancer Outreach Associates" in a lesser frequency.

Most popular intervention types in "Cancer Outreach Associates" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (3 trials), "APF530" (1 trials), "Carboplatin" (1 trials), "Docetaxel" (1 trials) and "EPO906 (Patupilone)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Outreach Associates" are 5 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Outreach Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Cancer Outreach Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Outreach Associates, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".